The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

T lymphocytes in vitro. The same occurs in vivo, in the tumor microenvironment and the administration of proton pump inhibitors, which buffer tumor acidity, can revert T-cell anergy and increase the efficacy of immunotherapy.